119 related articles for article (PubMed ID: 1808120)
21. Preparation, characterization, and evaluation of ioxilan carbonate particles for computed tomography contrast enhancement of liver.
Li C; Kan Z; Yang DJ; Kuang LR; Liu CW; Wright KC; Wallace S
Invest Radiol; 1994 Nov; 29(11):1006-13. PubMed ID: 7890508
[TBL] [Abstract][Full Text] [Related]
22. Distribution of contrast medium epidurally injected at thoracic and lumbar vertebral segments.
Zhang D; Fujiwara R; Iseri T; Nagahama S; Kakishima K; Kamata M; Mochizuki M; Nakagawa T; Sasaki N; Nishimura R
J Vet Med Sci; 2013; 75(5):663-6. PubMed ID: 23292108
[TBL] [Abstract][Full Text] [Related]
23. Clinical and nephrologic tolerance of iopromide and iotrolan in computed tomography.
Langer M; Langer R; Zwicker C; Speck U; Jänicke UA; Felix R
Invest Radiol; 1991 Nov; 26 Suppl 1():S83-5; discussion S88-91. PubMed ID: 1808156
[No Abstract] [Full Text] [Related]
24. Dose proportionality of iopromide pharmacokinetics and tolerability after i.v. injection in healthy volunteers.
Krause W; Schuhmann-Giampieri G; Staks T; Kaufmann J
Eur J Clin Pharmacol; 1994; 46(4):339-43. PubMed ID: 7957519
[TBL] [Abstract][Full Text] [Related]
25. Spatial and temporal mapping of heterogeneity in liposome uptake and microvascular distribution in an orthotopic tumor xenograft model.
Ekdawi SN; Stewart JM; Dunne M; Stapleton S; Mitsakakis N; Dou YN; Jaffray DA; Allen C
J Control Release; 2015 Jun; 207():101-11. PubMed ID: 25862513
[TBL] [Abstract][Full Text] [Related]
26. Determination of optimal dosage and delay time for computed tomographic lymphography after percutaneous injection of Iohexol into popliteal lymph nodes in dogs.
Chun H; Cho H; Cheon H; Kim J; Kim T; Kang JH; Kim G; Lee Y; Choi H; Lee H; Chang D
J Vet Med Sci; 2009 Jul; 71(7):873-8. PubMed ID: 19652472
[TBL] [Abstract][Full Text] [Related]
27. Time course of biodistribution and changes in density following administration of iobitridol in rabbits. A comparative study vs iohexol.
Rouleau P; Alison D; Bertrand P; Benderbous S; Havard P; Chambon C
Acta Radiol Suppl; 1996; 400():49-55. PubMed ID: 8619352
[TBL] [Abstract][Full Text] [Related]
28. CT blood pool enhancement in primates with lopromide-carrying liposomes containing soy phosphatidyl glycerol.
Schmiedl UP; Krause W; Leike J; Sachse A
Acad Radiol; 1999 Mar; 6(3):164-9. PubMed ID: 10898035
[TBL] [Abstract][Full Text] [Related]
29. Muscular and central nervous system side effects of intracarotid contrast media in rabbits.
Whisson CC; Evill CA; Wilson CA; Sage MR
Invest Radiol; 1990 Sep; 25 Suppl 1():S90-1. PubMed ID: 2283271
[No Abstract] [Full Text] [Related]
30. Dynamic contrast-enhanced computed tomography to assess antitumor treatment effects: comparison of two contrast agents with different pharmacokinetics.
Jost G; Pietsch H; Grenacher L
Invest Radiol; 2013 Oct; 48(10):715-21. PubMed ID: 23666093
[TBL] [Abstract][Full Text] [Related]
31. Significant perturbation in renal functional magnetic resonance imaging parameters and contrast retention for iodixanol compared with iopromide: an experimental study using blood-oxygen-level-dependent/diffusion-weighted magnetic resonance imaging and computed tomography in rats.
Wang YC; Tang A; Chang D; Zhang SJ; Ju S
Invest Radiol; 2014 Nov; 49(11):699-706. PubMed ID: 24879299
[TBL] [Abstract][Full Text] [Related]
32. The production and evaluation of contrast-carrying liposomes made with an automatic high-pressure system.
Cheng KT; Seltzer SE; Adams DF; Blau M
Invest Radiol; 1987 Jan; 22(1):47-55. PubMed ID: 3818235
[TBL] [Abstract][Full Text] [Related]
33. High iodine concentration contrast material for noninvasive multislice computed tomography coronary angiography: iopromide 370 versus iomeprol 400.
Cademartiri F; de Monye C; Pugliese F; Mollet NR; Runza G; van der Lugt A; Midiri M; de Feyter PJ; Lagalla R; Krestin GP
Invest Radiol; 2006 Mar; 41(3):349-53. PubMed ID: 16481919
[TBL] [Abstract][Full Text] [Related]
34. Contrast material-carrying liposomes: biodistribution, clearance, and imaging characteristics.
Seltzer SE; Blau M; Herman LW; Hooshmand RL; Herman LA; Adams DF; Minchey SR; Janoff AS
Radiology; 1995 Mar; 194(3):775-81. PubMed ID: 7862978
[TBL] [Abstract][Full Text] [Related]
35. Preclinical testing of iopromide. 1st communication: pharmacological evaluation.
Krause W; Press WR; Frenzel T
Arzneimittelforschung; 1994 Oct; 44(10):1162-6. PubMed ID: 7529504
[TBL] [Abstract][Full Text] [Related]
36. Comparative cytotoxicity of low-osmolar nonionic and high-osmolar ionic contrast media to dog gallbladder epithelial cells.
Ju YM; Kim MH; Lee SK; Seo DW; Min YI; Kim JY
Gastrointest Endosc; 2002 Mar; 55(3):382-6. PubMed ID: 11868013
[TBL] [Abstract][Full Text] [Related]
37. Quantitative CT imaging of the spatial and temporal distribution of liposomes in a rabbit tumor model.
Zheng J; Jaffray D; Allen C
Mol Pharm; 2009; 6(2):571-80. PubMed ID: 19298061
[TBL] [Abstract][Full Text] [Related]
38. Prevention of the hemodynamic effects of iopromide-carrying liposomes in rats and pigs.
Krause W; Gerlach S; Muschick P
Invest Radiol; 2000 Aug; 35(8):493-503. PubMed ID: 10946977
[TBL] [Abstract][Full Text] [Related]
39. Are iodinated contrast agents detrimental in acute cerebral ischemia? An experimental study in rats.
Doerfler A; Engelhorn T; von Kummer R; Weber J; Knauth M; Heiland S; Sartor K; Forsting M
Radiology; 1998 Jan; 206(1):211-7. PubMed ID: 9423675
[TBL] [Abstract][Full Text] [Related]
40. Liposomes carrying diatrizoate. Characterization of biophysical properties and imaging applications.
Seltzer SE; Davis MA; Adams DF; Shulkin PM; Landis WJ; Havron A
Invest Radiol; 1984; 19(2):142-51. PubMed ID: 6533105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
